Two Sigma Advisers
SANA icon

Two Sigma Advisers’s Sana Biotechnology SANA Stock Holding History

Two Sigma Advisers’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-221,671
Closed -$902K – 1751
2025
Q4 		$902K Buy
+221,671
New +$993K ﹤0.01% 1530
2025
Q3 		– Sell
-64,570
Closed -$176K – 2595
2025
Q2 		$176K Buy
+64,570
New +$133K ﹤0.01% 2145
2025
Q1 		– Sell
-209,000
Closed -$341K – 2557
2024
Q4 		$341K Buy
209,000
+182,100
+677% +$543K ﹤0.01% 1927
2024
Q3 		$112K Buy
26,900
+7,800
+41% +$41K ﹤0.01% 2155
2024
Q2 		$104K Buy
+19,100
New +$152K ﹤0.01% 2318
2024
Q1 		– Sell
-22,400
Closed -$91.4K – 2611
2023
Q4 		$91.4K Sell
22,400
-20,300
-48% -$74.8K ﹤0.01% 2332
2023
Q3 		$165K Sell
42,700
-17,800
-29% -$95.7K ﹤0.01% 2134
2023
Q2 		$361K Buy
60,500
+100
+0.2% +$576 ﹤0.01% 1924
2023
Q1 		$198K Buy
60,400
+18,000
+42% +$71.9K ﹤0.01% 2273
2022
Q4 		$167K Sell
42,400
-17,800
-30% -$87K ﹤0.01% 2219
2022
Q3 		$361K Sell
60,200
-24,000
-29% -$173K ﹤0.01% 1978
2022
Q2 		$541K Sell
84,200
-28,700
-25% -$183K ﹤0.01% 1884
2022
Q1 		$933K Buy
112,900
+92,000
+440% +$744K ﹤0.01% 1674
2021
Q4 		$324K Buy
+20,900
New +$403K ﹤0.01% 2120

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Two Sigma Advisers's SANA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 221,671 shares — an estimated $902K sold.

Two Sigma Advisers first reported a position in SANA in Q4 2021 and held it in 14 quarters. The position peaked at $933K in Q1 2022. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 221,671 Sana Biotechnology shares in Q1 2026, an estimated $902K.
  • Two Sigma Advisers first reported a position in Sana Biotechnology in Q4 2021 and held it in 14 quarters.
  • Two Sigma Advisers's Sana Biotechnology position peaked at $933K in Q1 2022.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.